TYNDALL CAPITAL PARTNERS L P 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | TYNDALL CAPITAL PARTNERS L P | 164,429 6.700% | 42,791 (+35.18%) | Filing |
| 2023-09-05 4:05 pm Purchase | 2023-08-23 | 13G | Cyclerion Therapeutics, Inc. CYCN | TYNDALL CAPITAL PARTNERS L P | 121,638 5.050% | 121,638 (New Position) | Filing |